Among the silenced genes was BCL11A, whose overexpression is observed in many hematological cancers and mediates its oncogenic role in leukemia via target genes Bcl2, Bcl2-xL, Mdm2, and p53 [47,48]. The gene discussed is BCL2; the disease is hematopoietic and lymphoid cell neoplasm.